RSS
|
Login
|
Register
HOME
SPECIALTY
Hematology-Oncology
Long Term Care
Nurse Practitioners
OB/GYN
Pharmacists
Physician Assistants
Primary Care Physicians
Residents
Urologists
THERAPEUTIC CATEGORIES
BRAND
GENERIC
COMPARE
NEWS
Drug News
Drugs in the Pipeline
Drug Safety Alerts and Recalls
New Drug Products
Polls & Surveys
Newsletters
News from Haymarket Journals
RESOURCES
Alerts (Sponsored)
Clinical Charts
Common Medical Abbreviations
Company
Drug Monograph Format
FDA Orange Book
Pharmacology Notes
Professional Associations
Video
Blogs
MPR Publications
Customer Service
Online Banner Ad Specs
Subscribe
DOWNLOAD
CME
JOBS
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Home
>
Specialty Pages
> Primary Care Physician Edition
Drug News
Silenor approved for insomnia
March 18, 2010
The FDA has approved Silenor (doxepin tablets, from Somaxon Pharmaceuticals) for the treatment of insomnia characterized by difficulty with sleep maintenance.
Hibiclens General Skin Cleansing Patient Kit available
March 17, 2010
Molnlycke Health Care announced the launch of Hibiclens General Skin Cleansing Patient Kit that is to be used at home prior to surgery as part of a strategy to minimize surgical-site infections and hospital-acquired infections.
Neosalus Cream available for dermatitis
March 16, 2010
Quinnova announced the launch of Neosalus Cream, a non-steroidal anti-inflammatory cream for the treatment of various dermatoses (eg, atopic dermatitis, contact dermatitis, and hand eczema).
Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)
March 12, 2010
The FDA has approved a five-day dosing regimen for Dacogen (decitabine for injection, from Eisai) to treat patients with myelodysplastic syndromes (MDS).
more »
Popular Categories
Cough & Cold
Hypertension
Bacterial Infections
Narcotic Analgesics
Hyperacidity, GERD and Ulcers
Drug Safety Alerts and Recalls
The Medicines Company expands Cleviprex recall
March 18, 2010
The FDA and The Medicines Company have notified healthcare professionals of an additional recall of 4 lots of Cleviprex (clevidipine butyrate injectable emulsion).
FDA halts marketing of unapproved nitroglycerin tablets
March 17, 2010
The FDA has ordered Glenmark Generics and Konec Inc. to stop marketing unapproved nitroglycerin tablets.
FDA warns of reduced Plavix efficacy in poor metabolizers
March 15, 2010
The FDA has notified healthcare professionals and patients that a Boxed Warning has been added to the Plavix (clopidogrel tablets, from Bristol-Myers Squibb and Sanofi) Prescribing Information to include information about reduced Plavix efficacy in patients who are poor metabolizers of Plavix.
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
March 11, 2010
The FDA has notified healthcare professionals and patients that at this point, the data that have been reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.
more »
New Product of the Week
VICTOZA
more »
Internal Medicine News from Healthday
Daily Internal Medicine News
clientId = "8D70113C"; newsFeed = "P"; newsType = "24"; category = "21"; numberReturn = "2"; landingUrl = "http://www.empr.com/healthday-article/section/943/";
Conference News
clientId = "8D70113C"; newsFeed = "P"; category = "21"; newsType = "26"; numberReturn = "2"; landingUrl = "http://www.empr.com/healthday-article/section/943/";
Round-up
clientId = "8D70113C"; newsFeed = "P"; category = "21"; newsType = "28"; numberReturn = "1"; landingUrl = "http://www.empr.com/healthday-article/section/943/";
more >
Courses from mycme.com
Course:
Vaccinating Schoolchildren: Next Step Forward in the Battle Against Influenza?
Underdiagnosis & Undertreatment of Pain
Credit:
1.00 / AMA PRA Category 1 Credit
1.00 / AMA PRA Category 1 Credit
Profession:
Physicians
Physicians
Expires
:
10/31/2010
5/31/2010
Start now!
Start now!
Visit mycme.com
Primary Care Links
Physician Associations
Alternative Medicine Index
mycme.com
eMPR Download
The Clinical Advisor
Cortlandt Forum
How important are
herbals and supplements
to your practice?
Please take this short survey
and let us know.
Chart of the Week
Recommended Adult Immunization Schedule
Our featured chart has been updated to assist your clinical decisions.
View the
Recommended Adult Immunization Schedule
chart.
COLORECTAL CANCER AWARENESS MONTH
This March,
MPR
is honoring
Colorectal Cancer Awareness Month
w
ith a special drug information newsletter containing state-of-the-art information on the diagnosis, treatment, and prevention for colorectal cancer, as well as intriguing new research
View this month's
MPR Seasonal Spotlight
Subscribe
to the MPR Seasonal Spotlight
Updated Drugs
OFORTA
Neoplasms > Antimetabolites
Monograph added.
Updated:
3/18/2010
PROTONIX TABLETS
Gastrointestinal Tract > Hyperacidity, GERD, and ulcers
Children: added dosing for erosive esophagitis. Interactions: added concomitant atazanivir or nelfinavir: not recommended.
Updated:
3/17/2010
LAMICTAL XR
Central Nervous System > Seizure disorders
Indications: added adjunct in primary generalized tonic-clonic seizures.
Updated:
3/16/2010
more »
Primary Care Jobs
Get the
RSS Widget
widget and many other
great free widgets
at
Widgetbox
! Not seeing a widget? (
More info
)
Click here for RSS feed
Sponsored Alerts
New Product: SAPHRIS® (asenapine) Sublingual Tablets
more »
Stay Connected
Follow us on Twitter
Join us on Facebook
Most Popular
Most Emailed
Most Recent
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Trelstar 22.5mg approved for palliative treatment of prostate cancer
FDA halts marketing of unapproved nitroglycerin tablets
FDA accepts NDA for lurasidone, a treatment for schizophrenia
Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)
Neosalus Cream available for dermatitis
Hibiclens General Skin Cleansing Patient Kit available
Bowel Cleansers
FDA warns of reduced Plavix efficacy in poor metabolizers
Silenor approved for insomnia
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Recommended Adult Immunization Schedule
Prevnar 13 pneumococcal disease vaccine approved
Neosalus Cream available for dermatitis
Xiaflex available for Dupuytren's contracture
Hizentra approved for primary immunodeficiency
Kapidex to be marketed under new trade name Dexilant
Ampyra available for multiple sclerosis patients
FDA grants priority review to Tasigna for newly diagnosed chronic myeloid leukemia
FDA accepts NDA for JZP-6, a treatment for fibromyalgia
Silenor approved for insomnia
The Medicines Company expands Cleviprex recall
FDA halts marketing of unapproved nitroglycerin tablets
Hibiclens General Skin Cleansing Patient Kit available
Bowel Cleansers
Neosalus Cream available for dermatitis
FDA warns of reduced Plavix efficacy in poor metabolizers
Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)
FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
Trelstar 22.5mg approved for palliative treatment of prostate cancer
Sponsored Links